ACCUPRIL

This brand name is authorized in Australia, Canada, United States, South Africa

Active ingredients

The drug ACCUPRIL contains one active pharmaceutical ingredient (API):

1 Quinapril UNII 33067B3N2M - QUINAPRIL HYDROCHLORIDE

Quinapril is a potent angiotensin-converting enzyme (ACE) inhibitor. The mode of action of quinapril in humans and animals is to inhibit circulating and tissue ACE activity, thereby decreasing vasopressor activity and aldosterone secretion. Read about Quinapril

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ACCUPRIL Film-coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09AA06	Quinapril	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1968N, 1969P, 1970Q
Country: CA	Health Products and Food Branch	Identifier(s): 01947664, 01947672, 01947680, 01947699
Country: US	FDA, National Drug Code	Identifier(s): 0071-0527, 0071-0530, 0071-0532, 0071-0535
Country: ZA	Health Products Regulatory Authority	Identifier(s): W/7.1.3/361, W/7.1.3/362, W/7.1.3/363, W/7.1.3/364